PURPOSE: To evaluate disease-specific differences between Myasthenia Gravis (MG) subgroups and compare patterns of lifestyle between MG patients and population controls. METHODS: All MG patients (n=70) in Jönköping County, Sweden, were invited to answer a disease-specific questionnaire, containing questions about disease-specific data, lifestyle, co-morbidity and mental fatigue. The patients were clinically evaluated. Four hundred age- and gender matched population controls were invited to answer the non-disease-specific part of the questionnaire. Disease-specific issues were compared between MG subgroups. Lifestyle related factors and concomitant conditions were compared to the population controls. RESULTS: Forty MG patients and 188 popula...
Aims: To examine healthcare resource utilization associated with refractory myasthenia gravis (MG) i...
Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the acetylcholine recept...
Contains fulltext : 99384.pdf (publisher's version ) (Open Access)The aim of the s...
Background and Objectives: To describe myasthenia gravis activities of daily living (MG-ADL) in rela...
Myasthenia Gravis (MG) is an autoimmune disease caused by antibodies directed against proteins at th...
Tntroduction: Self-estimated health can be used for comparison of different diseases between countri...
Myasthenia gravis (MG) is a disorder of the neuromuscular junction (NMJ) that causes fatigue and flu...
INTRODUCTION: Social determinants of health (SDOH) are important contributors to health outcomes, an...
Abstract Current available therapies control Myasthenia gravis (MG) reasonably well,...
We performed a community-based survey of 165 Australian patients with a physician-confirmed diagnosi...
PURPOSE:As most of patients with Myasthenia Gravis have limitations in their physical functioning, m...
A multicentre retrospective study was carried out on the characteristics and course of myasthenia gr...
AimsTo explore the quality of life (QOL) in patients with myasthenia gravis (MG) and factors associa...
Objective: To describe the characteristics of patients with very-late-onset myasthenia gravis (MG). ...
Objectives Myasthenia gravis (MG) is a rare, chronic, autoimmune neuromuscular disease which can aff...
Aims: To examine healthcare resource utilization associated with refractory myasthenia gravis (MG) i...
Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the acetylcholine recept...
Contains fulltext : 99384.pdf (publisher's version ) (Open Access)The aim of the s...
Background and Objectives: To describe myasthenia gravis activities of daily living (MG-ADL) in rela...
Myasthenia Gravis (MG) is an autoimmune disease caused by antibodies directed against proteins at th...
Tntroduction: Self-estimated health can be used for comparison of different diseases between countri...
Myasthenia gravis (MG) is a disorder of the neuromuscular junction (NMJ) that causes fatigue and flu...
INTRODUCTION: Social determinants of health (SDOH) are important contributors to health outcomes, an...
Abstract Current available therapies control Myasthenia gravis (MG) reasonably well,...
We performed a community-based survey of 165 Australian patients with a physician-confirmed diagnosi...
PURPOSE:As most of patients with Myasthenia Gravis have limitations in their physical functioning, m...
A multicentre retrospective study was carried out on the characteristics and course of myasthenia gr...
AimsTo explore the quality of life (QOL) in patients with myasthenia gravis (MG) and factors associa...
Objective: To describe the characteristics of patients with very-late-onset myasthenia gravis (MG). ...
Objectives Myasthenia gravis (MG) is a rare, chronic, autoimmune neuromuscular disease which can aff...
Aims: To examine healthcare resource utilization associated with refractory myasthenia gravis (MG) i...
Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the acetylcholine recept...
Contains fulltext : 99384.pdf (publisher's version ) (Open Access)The aim of the s...